ITOS IPOs 12.17M* shares @19.00: https://www.globenewswire.com/news-release/2020/07/24/2067073/0/en/iTeos-Therapeutics-Announces-Pricing-of-Initial-Public-Offering.html iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients.*Assuming exercise of underwriter’s option.